FBT

First Trust NYSE Arca Biotechnology Index Fund

Down$139.97
$-0.89
(-0.63%)
As of 7:40:00 PM EDT | 1/23/19  |  Market Closed

FBT Trading Data

Open

$141.32

Low Price

$137.9

High Price

$142.51

Previous Last Price

$140.86

Bid Size

$137.66 X 700

Ask Size

$143.22 X 700

FBT Portfolio Data

AUM

$2,675,009,800

Shares

19,000

PE Ratio

19.7

Price / Book Ratio

6.09

Expense Ratio

0.56

Net Asset Value

$140.79

Volume

Volume

117,700

Avg. Volume (YDT)

181,080

Dollar Volume

$14,124,320

Weekly Avg. Volume

153,280

Monthly Avg. Volume

220,515

Quarterly Avg. Volume

287,990

FBT Fund Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October to ensure that each component stock continues to represent approximately equal weight in the index.

FBT Chart

FBT Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust NYSE Arca Biotechnology Index Fund

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

FBT Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

FBT Holdings

Top 10 Holdings

Exelixis Inc. (EXEL)
4.75%
Ionis Pharmaceuticals Inc. (IONS)
4.31%
Intercept Pharmaceuticals Inc. (ICPT)
4.15%
Illumina Inc. (ILMN)
3.83%
Charles River Laboratories International Inc. (CRL)
3.76%
Alnylam Pharmaceuticals Inc. (ALNY)
3.7%
Incyte Corporation (INCY)
3.69%
Biogen Inc. (BIIB)
3.61%
Regeneron Pharmaceuticals Inc. (REGN)
3.6%
Grifols S.A. (ADR) (GRFS)
3.59%

Total FBT Holdings

Total Holdings: 31

Exelixis Inc. (EXEL)
4.75%
Ionis Pharmaceuticals Inc. (IONS)
4.31%
Intercept Pharmaceuticals Inc. (ICPT)
4.15%
Illumina Inc. (ILMN)
3.83%
Charles River Laboratories International Inc. (CRL)
3.76%
Alnylam Pharmaceuticals Inc. (ALNY)
3.7%
Incyte Corporation (INCY)
3.69%
Biogen Inc. (BIIB)
3.61%
Regeneron Pharmaceuticals Inc. (REGN)
3.6%
Grifols S.A. (ADR) (GRFS)
3.59%
Vertex Pharmaceuticals Incorporated (VRTX)
3.56%
QIAGEN N.V. (QGEN)
3.54%
Amgen Inc. (AMGN)
3.5%
IQVIA Holdings Inc. (IQV)
3.42%
BioMarin Pharmaceutical Inc. (BMRN)
3.32%
Gilead Sciences Inc. (GILD)
3.29%
United Therapeutics Corporation (UTHR)
3.23%
Alexion Pharmaceuticals Inc. (ALXN)
3.2%
bluebird bio Inc. (BLUE)
3.15%
Bio-Techne Corporation (TECH)
3.13%
Seattle Genetics Inc. (SGEN)
3.1%
Celgene Corporation (CELG)
3.04%
Alkermes Plc (ALKS)
3.01%
ACADIA Pharmaceuticals Inc. (ACAD)
2.93%
Agios Pharmaceuticals Inc. (AGIO)
2.83%
Nektar Therapeutics (NKTR)
2.79%
FibroGen Inc. (FGEN)
2.75%
Ultragenyx Pharmaceutical Inc. (RARE)
2.67%
Neurocrine Biosciences Inc. (NBIX)
2.34%
Intrexon Corporation (XON)
2.19%
First Trust NYSE Arca Biotechnology Index Fund (FBT)
0%

FBT Technicals

Alpha

-3.68

Beta

1.38

Leverage

Long

Standard Deviation

10.95

FBT Dividends

Dividend Date

2015-09-23

Latest Dividend

0.02

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FBT Performance

YTD Return

12.7%

1 Year Return

-2.36%

3 Year Return

63.14%

5 Year Return

85.98%

10 Year Return

624.86%

FBT Related Articles